Document is current
Any future updates will be listed below
-
Authors
Yilmaz, Enis C.
Harmon, Stephanie A.
Lis, Rosina T.
Esengur, Omer Tarik
Gelikman, David G.
Garmendia-Cedillos, Marcial
Merino, Maria J.
Wood, Bradford J.
Patel, Krishnan
Citrin, Deborah E.
Gurram, Sandeep
Choyke, Peter L.
Pinto, Peter A.
Turkbey, Baris
-
Funding
Funding for this research was provided by:
National Cancer Institute
- License Information
-
More Information
Article History
Received: 7 September 2024
Revised: 26 November 2024
Accepted: 30 November 2024
First Online: 11 December 2024
Declarations
:
: Bradford J. Wood: Principal investigator on cooperative research and development agreement (CRADA) between National Institutes of Health (NIH) and Philips and CRADAs with industry partners unrelated to this work; travel support related to CRADAs; royalties from NIH related to Philips licensing agreement; patents planned, issued, or pending. Peter L. Choyke: Receives payment from royalties paid to the U.S. government for patents on MRI US fusion biopsy licensed to Philips Medical.Peter A. Pinto: Institutional CRADA with Philips; royalties from NIH related to Philips licensing agreement; NIH-related patents planned, issued, or pending (U.S. patent nos. 8 447 384 and 10 215 830).Baris Turkbey: CRADAs with NVIDIA and Philips; royalties from NIH; patents planned, issued, or pending in the field of artificial intelligence.
